Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109205) titled 'A study of Intralesional Botulinum Toxin A vs Triamcinolone Acetonide for Management of Hypertrophic Scars' on April 23.
Study Type: Interventional
Study Design:
Randomized, Parallel Group Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Sequentially numbered, sealed, opaque envelopes Blinding and masking:Outcome Assessor Blinded
Primary Sponsor: Dr Nishita Maheshwari
Condition:
Health Condition 1: L910- Hypertrophic scar
Intervention:
Intervention1: Botulinum Toxin Type A: Preparation: Reconstitution of 100 U vial with 2.5 mL sterile...